시장보고서
상품코드
1944426

제약 분무 건조 시장 : 제품 종류별, 건조 방법별, 용도별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율, 예측(2025-2032년)

Pharmaceutical Spray Drying Market, By Product Type, By Drying Configuration, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 352 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

제약 분무 건조 시장 규모는 2024년에 21억 3,030만 달러로 평가되었으며, 2025년부터 2032년까지 CAGR 7.50%로 확대될 전망입니다.

제약 분무 건조 시장은 용액, 현탁액, 에멀전과 같은 액체 의약품 원료를 입자 크기, 모양, 밀도, 수분 또는 잔류 용매 수준을 제어하여 건조하고 유동적인 분말로 변환하는 분무 건조 기술의 활용에 초점을 맞추고 있습니다. 제약 연구 및 제조 분야에서 분무 건조는 단순한 건조 공정 이상의 기술로 널리 인식되고 있습니다. 이는 특정 성능 목표를 위한 입자 설계가 가능하기 때문입니다. 특히 수용성이 낮은 화합물, 불안정한 유효성분, 용해도와 분산성을 정밀하게 제어해야 하는 제제 등 기존 공정으로 요구되는 분말 특성을 달성할 수 없는 경우에 많이 선택되고 있습니다.

이 시장의 성장은 난용성 저분자 후보물질의 증가, 비정질 고체 분산액과 같은 제형 기술에 대한 니즈, 그리고 공기역학적 입자 크기가 중요한 품질 특성이 되는 흡입 및 비강용 의약품의 꾸준한 확대와 밀접한 관련이 있습니다. 또한, 맛 마스킹, 서방성 제어, 민감한 활성 성분의 안정화 및 혼합, 캡슐화, 정제화 등 다운스트림 공정의 제조성 향상에도 적용 가능합니다. R&D 및 공정 개발 팀에게 이 기술은 신속한 제형 스크리닝, 예측 가능한 파라미터 기반 입자 특성 조정, 공정 이해 및 품질 설계(QbD) 프레임워크를 통한 명확한 스케일업 경로를 제공한다는 점에서 높은 평가를 받고 있습니다.

제약 분무 건조의 시장 역학

난용성 신약의 증가와 활발한 승인 주기로 인해 제형 실현을 위한 분무 건조 추진

제약 분무 건조 시장의 주요 촉진요인은 꾸준한 신약 승인과 물에 잘 녹지 않는 분자에 대한 '솔루션'에 대한 요구가 증가하고 있다는 점입니다. 용해도가 낮으면 흡수율이 떨어지거나 변동이 발생하여 제형 팀은 분무 건조된 비정질 고체 분산액이나 정밀하게 설계된 건조 분말과 같은 효과적인 접근 방식을 채택해야 합니다. 미국 식품의약국(FDA) 의약품평가연구센터(CDER)에 따르면, 2021년 50건, 2022년 37건, 2023년 55건, 2024년 50건, 2021년부터 2024년까지의 누적 승인 건수는 192건에 달합니다.는 192건에 달합니다. 이러한 상황은 R&D 및 제조 부문에 확장 가능한 프로세스를 조기에 선택하도록 압력을 가하고 있습니다. 제조 부문에서도 확장 가능한 프로세스를 조기에 선택해야 할 필요성이 대두되고 있습니다. 파이프라인 수준에서는 여전히 임상시험의 부하가 크게 지속되고 있습니다. ClinicalTrials.gov(미국 국립의학도서관, NIH)에 따르면, 이 등록기관에는 총 수십만 건의 연구가 등록되어 있으며, 최근 수만 건의 연구가 진행 중이거나 피험자를 모집 중으로, 궁극적으로 제제 최적화 및 기술이전이 필요한 광범위한 프로그램 기반이 존재함을 보여줍니다. 생산 측면에서는 신뢰할 수 있고 반복 가능한 제조 공정에 대한 수요가 입자 공학 및 건조 기술에 대한 투자를 뒷받침하고 있습니다. 미국 인구조사국(의약품 및 의약외품 제조 통계)에 따르면, 2020년대 초 업계 출하액은 수 천억 달러 규모로 보고되고 있으며, 수율, 배치 간 균일성, 사이클 타임을 조금만 개선해도 비용 절감과 공급 안정화에 크게 기여할 수 있습니다. 이러한 활발한 승인 주기, 대규모 임상 파이프라인, 고부가가치 생산량과 함께 표준 결정화 및 분쇄로는 충분하지 않은 경우가 증가하고 있으며, GMP 요건 하에서 입자 특성을 제어하고 용해도를 개선하며 스케일업 위험을 줄이기 위한 실용적인 대안으로 분무 건조가 선택되고 있습니다. 선택되고 있습니다.

제약 분무 건조 시장 : 세분화 분석

개발 파이프라인이 활발하게 진행되고 있고, 많은 의약품 프로그램이 전문 GMP 시설, 용매 처리, 새로운 사내 설비를 기다리지 않고 신속한 기술 이전을 필요로 하기 때문에 위탁 분무 건조 및 가공에 대한 관심이 계속 증가하고 있습니다. ClinicalTrials.gov(미국 국립의학도서관, NIH)에 따르면, 이 데이터베이스는 2020년대에 40만 건을 훨씬 넘는 등록 시험으로 확대되었으며, 최근에는 수만 건이 '진행 중' 또는 '피험자 모집 중'이라고 명시되어 있습니다. 이는 제제 개발 및 공정 개발 작업이 조사개발 단계를 통해 꾸준히 진행되고 있음을 보여줍니다. 이 작업량은 상용화 준비와 직결됩니다. 각 성공 프로그램은 궁극적으로 확장 가능하고 문서화된 제조 경로가 필요하기 때문입니다. 미국 FDA 의약품평가연구센터(CDER)에 따르면, 2021년 50건, 2022년 37건, 2023년 55건, 2024년 50건으로 2021-2024년 누적 192건에 달할 것으로 예상됩니다. 이러한 승인 수준은 제조업체와 위탁 파트너에게 프로세스 구축, 검증 수행, 제품 출시 지원을 위한 지속적인 압력을 가하고 있습니다. 특히 입자 설계 및 분말 품질 안정화에서 분무 건조가 자주 고려됩니다.

또한, 제제 제조에서도 분무 건조에 대한 수요를 뒷받침하고 있습니다. 상업적 생산에서는 배치 간 일관성, 예측 가능한 분말 유동성 및 혼합, 충전, 캡슐화, 타정, 흡입 장치 성능과 같은 다운스트림 공정에 대한 입자 특성 제어가 매우 중요하기 때문입니다. 미국 인구조사국(NAICS 3254, 의약품 및 의약외품 제조업 통계)에 따르면, 2020년대 초 미국 내 해당 산업의 출하액은 수 천억 달러에 달하는 것으로 보고되고 있으며, 수율, 사이클 타임, 편차 값의 작은 공정 개선도 대규모 사업 규모에서는 재무적으로 큰 영향을 미칠 수 있음을 보여줍니다. 이와 함께 미국 FDA 의약품평가연구센터(CDER)의 연례 의약품 승인 보고서에 따르면 2020년부터 2024년까지 지속적으로 승인되는 신약은 스케일업, 승인 후 공정 변경, 세컨드 소스 계획과 같은 라이프사이클 제조 활동을 뒷받침하고 있습니다. 이 모든 것은 제품 성능이 엄격한 입자 제어에 의존하는 경우 분무 건조와 같은 견고하고 재현성이 높은 분말 처리 방법을 유리하게 만듭니다.

제약 분무 건조 시장 - 지역별 분석

제약 분무 건조 수요는 의약품 개발 활동과 GMP 생산량이 지속적으로 높은 지역에 집중되는 경향이 있습니다. 이는 스케일업이나 상업적 공급으로 전환할 수 있는 파이프라인이 존재할 때 분무 건조가 채택되기 때문입니다. 미국 FDA 의약품평가연구센터(CDER)에 따르면, 2021년 50건, 2022년 37건, 2023년 55건, 2024년 50건, 2021년부터 2024년까지 누적 192건의 신규 분자 실체 승인 건수를 기록할 예정입니다. 이는 제조 준비가 완료된 제형 결정과 제어된 분말 처리가 필요한 제품을 안정적으로 공급할 수 있다는 것을 의미합니다. 유럽의약품청(EMA)에 따르면, 2020년대 초까지 높은 수준의 평가 및 승인 활동을 지속하고 있으며, 이는 규정 준수 및 문서화에 대한 요구 수준이 높은 유럽에서 첨단 가공 기술에 대한 지속적인 수요를 뒷받침하고 있다고 합니다. 아시아 전역에서 규제 대상 제조 및 수출 지향적 생산의 성장과 함께 투자가 이루어지는 경향이 있습니다. 세계보건기구(WHO)의 2020년대 초 규제 시스템 강화에 관한 간행물에 따르면, 더 많은 국가들이 규제 기능의 성숙도를 높이기 위해 노력하고 있으며, 이는 일반적으로 GMP 준수 기술 및 전문 위탁 제조 능력의 광범위한 채택을 뒷받침합니다.

미국 제약 분무 건조 시장 - 국가별 분석

미국은 승인 건수, 임상 활동, 대규모 생산의 경제성을 겸비하고 있어 단일 국가로는 가장 유력한 시장 기회로 여겨집니다. 미국 FDA 의약품평가연구센터(CDER)에 따르면, 2021년부터 2024년까지 신규 분자(NME) 승인 속도는 높은 수준을 유지하고 있으며, 연간 승인 건수는 50건, 37건, 55건, 50건입니다. 이는 제품 출시 일정과 라이프사이클 제조 업무에 활기를 불어넣고, 분무 건조와 같은 확장 가능한 입자 공학 공정에 대한 투자를 촉진하고 있습니다. 개발의 깊이도 여전히 두드러집니다. ClinicalTrials.gov(미국 국립의학도서관, NIH)에 따르면, 2020년대에 등록된 임상시험은 40만 건을 훌쩍 넘어섰으며, 최근 몇 년 동안 '진행 중' 또는 '피험자 모집 중'인 임상시험이 매우 많아 제제 개발 및 공정 최적화에 대한 지속적인 수요를 뒷받침하고 있습니다. 제조 기반도 충분히 대규모이기 때문에 약간의 효율 개선도 큰 영향을 미칠 수 있습니다. 미국 인구조사국(의약품 및 의약외품 제조업, NAICS 3254)에 따르면 2020년대 초 출하액은 수 천억 달러에 달할 것으로 예상되며, 이는 수율, 배치 간 일관성, 봉쇄 성능, 용매 처리 능력, 장비 및 아웃소싱 서비스 모두에서 실용적인 구매 기준이 될 수 있는 이유를 뒷받침합니다.

목차

제1장 제약 분무 건조 시장 개요

제2장 주요 요약

제3장 제약 분무 건조의 주요 시장 동향

제4장 제약 분무 건조 시장 : 산업 분석

제5장 제약 분무 건조 시장 : 높아지는 지정학적 긴장의 영향

제6장 제약 분무 건조 시장 구도

제7장 제약 분무 건조 시장 : 제품 종류별

제8장 제약 분무 건조 시장 : 건조 방법별

제9장 제약 분무 건조 시장 : 용도별

제10장 제약 분무 건조 시장 : 최종사용자별

제11장 제약 분무 건조 시장 : 지역별

제12장 주요 벤더 분석 : 제약 분무 건조 산업

제13장 AnalystView의 전방위적 분석

KSM 26.03.13

Pharmaceutical Spray Drying Market size was valued at US$ 2,130.30 Million in 2024, expanding at a CAGR of 7.50% from 2025 to 2032.

The pharmaceutical spray drying market focuses on the use of spray drying to turn liquid drug feeds such as solutions, suspensions, or emulsions into dry, free-flowing powders with controlled particle size, shape, density, and moisture or residual solvent levels. In pharmaceutical research and manufacturing, spray drying is widely treated as more than a simple drying step because it can be used to engineer particles for specific performance targets. It is often chosen when conventional processing cannot achieve the required powder properties, especially for compounds with poor water solubility, unstable actives, or formulations that need precise control over dissolution and dispersibility.

Growth in this market is closely linked to the increasing number of poorly soluble small-molecule candidates and the need for enabling formulation approaches such as amorphous solid dispersions, as well as the steady expansion of inhalation and nasal drug products where aerodynamic particle size is a critical quality attribute. Spray drying is also applied for taste masking, controlled release, stabilization of sensitive actives, and improving downstream manufacturability for blending, encapsulation, and tableting. For R&D and process development teams, the technology is valued for rapid formulation screening, predictable parameter-based tuning of particle properties, and a clearer path for scale-up when supported by process understanding and Quality by Design frameworks.

Pharmaceutical Spray Drying Market- Market Dynamics

More Poorly Soluble New Drugs and a Busy Approval Cycle Are Driving Spray Drying for Enabling Formulations

A key driver for the pharmaceutical spray drying market is the steady flow of new drug approvals and the growing need to "fix" molecules that do not dissolve well in water, since poor solubility often leads to low and variable absorption and forces formulation teams to use enabling approaches like spray-dried amorphous solid dispersions or carefully engineered dry powders. The scale of development work is clear in recent approval volumes: According to the U.S. Food and Drug Administration (FDA) CDER, new molecular entity approvals were 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, adding up to 192 NMEs across 2021-2024, which keeps pressure on R&D and manufacturing groups to select scalable processes early. At the pipeline level, the clinical workload remains large and continuous: According to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the registry contains hundreds of thousands of studies overall, with tens of thousands in active or recruiting status in recent years, pointing to a wide base of programs that eventually require formulation optimization and tech transfer. On the production side, demand for reliable, repeatable manufacturing supports investment in particle engineering and drying technologies: According to the U.S. Census Bureau (manufacturing statistics for pharmaceutical and medicine manufacturing), industry shipment values in the early 2020s are reported at hundreds of billions of dollars, meaning small gains in yield, batch consistency, and cycle time can translate into meaningful cost and supply improvements. This combination of a busy approval cycle, a large clinical pipeline, and high-value manufacturing output increases the number of cases where standard crystallization or milling is not enough, making spray drying a practical choice to control particle properties, improve dissolution, and reduce scale-up risk under GMP expectations.

Pharmaceutical Spray Drying Market- Segmentation Analysis:

Outsourced spray drying and processing keeps gaining attention because the development pipeline stays busy and many drug programs need specialized GMP facilities, solvent handling, and fast tech transfer without waiting for new internal capacity. According to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the database has grown to well over 400,000 registered studies in the 2020s, with tens of thousands listed as active or recruiting in recent years, which points to a steady stream of formulation and process work moving through R&D. That workload connects directly to commercial readiness, since each successful program eventually needs a scalable and documented manufacturing route. According to U.S. FDA CDER, new molecular entity approvals reached 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, which adds up to 192 NMEs over 2021-2024; this level of approvals keeps pressure on manufacturers and contract partners to lock processes, run validation campaigns, and support launches where spray drying is often considered for particle engineering and consistent powder quality.

Finished dosage manufacturing also supports demand for spray drying because commercial production places high value on batch consistency, predictable powder flow, and controlled particle properties for downstream steps like blending, filling, encapsulation, tableting, or inhalation device performance. According to the U.S. Census Bureau (manufacturing statistics for pharmaceutical and medicine manufacturing, NAICS 3254), U.S. shipment values for this industry are reported in the hundreds of billions of dollars in the early 2020s, showing how even small process gains in yield, cycle time, and deviations can matter financially at scale. Alongside this, according to U.S. FDA CDER annual drug approval reporting, the continuing flow of novel approvals through 2020-2024 supports ongoing lifecycle manufacturing activities such as scale-up, post-approval process changes, and second-source planning, all of which favor robust, repeatable powder-processing methods like spray drying when product performance depends on tight particle control.

Pharmaceutical Spray Drying Market- Geographical Insights

Pharmaceutical spray drying demand tends to concentrate in regions where drug development activity and GMP manufacturing output stay high, because spray drying is usually adopted when a pipeline exists that can move into scale-up and commercial supply. According to U.S. FDA CDER, new molecular entity approvals were 50 in 2021, 37 in 2022, 55 in 2023, and 50 in 2024, adding up to 192 approvals across 2021-2024, which signals a steady flow of products that need manufacturing-ready formulation decisions and controlled powder processing. According to the European Medicines Agency (EMA), the agency continued to publish strong levels of evaluation and authorization activity through the early 2020s, supporting ongoing demand for advanced processing technologies in Europe where compliance and documentation expectations are high. Across Asia, investment tends to follow growth in regulated manufacturing and export-oriented production; according to the World Health Organization (WHO) regulatory system strengthening publications in the early 2020s, more countries have been progressing toward higher maturity regulatory functions, which typically supports broader adoption of GMP-aligned technologies and specialized contract manufacturing capacity.

United States Pharmaceutical Spray Drying Market- Country Insights

The United States looks like the strongest single-country opportunity because it combines approvals, clinical activity, and large-scale manufacturing economics. According to U.S. FDA CDER, the 2021-2024 NME approval run-rate remained high, with annual counts of 50, 37, 55, and 50, which keeps launch timelines and lifecycle manufacturing work active and encourages investment in scalable particle engineering routes such as spray drying. Development depth also remains visible; according to ClinicalTrials.gov (U.S. National Library of Medicine, NIH), the registry includes well over 400,000 studies in total in the 2020s, with a very large number of trials listed as active or recruiting in recent years, which supports continued demand for formulation development and process optimization. The manufacturing base is also large enough for small efficiency improvements to matter; according to the U.S. Census Bureau (pharmaceutical and medicine manufacturing, NAICS 3254), shipment values are reported in the hundreds of billions of dollars in the early 2020s, reinforcing why yield, batch consistency, containment, and solvent-handling capability become practical buying criteria for both equipment and outsourced services.

Pharmaceutical Spray Drying Market- Competitive Landscape:

The competitive landscape usually splits into equipment suppliers focused on lab-to-commercial spray drying systems and CDMOs that offer development plus GMP spray drying as a service, often bundled with analytical testing and regulatory documentation. Commonly referenced equipment vendors include GEA Group Aktiengesellschaft (strong in large-scale system engineering and global service coverage), BUCHI Labortechnik AG (strong in laboratory and pilot tools used in formulation screening and process development), SPX FLOW, Inc. (strong in industrial drying experience and custom builds), Yamato Scientific Co., Ltd. (strong in lab-scale penetration in research environments), and Glatt GmbH (strong in pharmaceutical process equipment engineering and GMP-oriented designs). Commonly referenced service-oriented vendors include Catalent, Inc. (strong in moving programs from development into commercial manufacturing), Lonza Group AG (strong in global GMP manufacturing networks and complex programs), and Hovione, S.A. (strong in particle engineering and enabling formulation work, including inhalation-focused development). In purchasing decisions, the main differentiators tend to be proven scale-up performance, containment level for potent compounds, solvent safety and recovery options, analytical capability for particle and solid-state characterization, and inspection-ready quality systems that reduce technical and regulatory risk.

Recent Developments:

In November 2025, Hovione (a Portugal-based contract development and manufacturing organization, CDMO) completed an initial US$100 million investment round to expand its East Windsor, New Jersey site, taking the footprint to more than 200,000 sq. ft. and more than doubling spray-drying capacity; the first phase adds a 31,000-sq.-ft. building with two size-3 spray dryers (PSD-3) for amorphous solid dispersion (ASD) production, with construction underway and GMP operations targeted for Q2 2026.

In October 2025, Codis (a CDMO formed from the combination of U.S.-based Particle Dynamics and a U.K. spray drying site previously operated by EuroAPI) launched with over 5,000 metric tons per year of spray-drying output capacity, more than 300 employees globally, and 40,000 square meters of manufacturing space across three GMP facilities, positioning the business for commercial-scale ASD, particle engineering, and finished dose manufacturing, while noting seven regulatory approvals achieved.

In September 2024, Seran Bioscience (a CDMO providing development, analytical, and manufacturing services) announced a strategic growth transaction of more than US$200 million led by Bain Capital Life Sciences (with Vivo Capital remaining a key shareholder) to support construction of a new commercial-scale manufacturing facility planned for completion in 2026, expanding integrated capabilities across oral, pulmonary, and nasal delivery with particle-engineering technologies including spray drying, hot melt extrusion, nano-milling, and fluid-bed manufacturing, plus finished dose and packaging/serialization; the company cited 200+ team members (including 150+ scientists and engineers) and plans to hire up to 150 additional employees, building toward a nearly 200,000-sq.-ft. campus in Bend, Oregon.

In September 2024, Evonik (a specialty chemicals company and pharmaceutical excipient supplier) opened a new Darmstadt facility for drying aqueous dispersions of EUDRAGIT(R) polymers, described as a double-digit million-euro investment to expand excipient capacity for oral drug delivery, improve supply security and delivery times, and operate with green electricity and steam from local waste incineration, targeting savings of more than 1,000 CO2 equivalents per year and alignment with IPEC-GMP guidelines through direct connection to its EUDRAGIT(R) dispersion production.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • BUCHI Labortechnik AG
  • Catalent, Inc.
  • Dedert Corporation
  • European SprayDry Technologies LLP
  • Fette Compacting GmbH
  • GEA Group Aktiengesellschaft
  • Glatt GmbH
  • GMP Pharmaceuticals, LLC
  • Hovione, S.A.
  • Labultima
  • Lonza Group AG
  • Merck KGaA
  • New AVM Systech Pvt. Ltd.
  • SiccaDania A/S
  • SPX FLOW, Inc.
  • SUDMO GmbH
  • Swenson Technology, Inc.
  • Tetra Pak International S.A.
  • Thermo Fisher Scientific Inc.
  • Yamato Scientific Co., Ltd.
  • Others

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Spray Dryers (equipment)
  • Accessories/Consumables
  • Services (contract spray drying/processing)

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY DRYING CONFIGURATION- MARKET ANALYSIS, 2019 - 2032

  • Co-current
  • Counter-current
  • Mixed-flow

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • APIs (active pharmaceutical ingredients)
  • Excipients
  • Finished Dosage Forms (e.g., inhalation, oral solid dosage)

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Development & Manufacturing Organizations (CDMOs/CMOs)
  • Research Institutes & Laboratories

GLOBAL PHARMACEUTICAL SPRAY DRYING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Spray Drying Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Spray Drying Market Snippet by Product Type
    • 2.1.2. Pharmaceutical Spray Drying Market Snippet by Drying Configuration
    • 2.1.3. Pharmaceutical Spray Drying Market Snippet by Application
    • 2.1.4. Pharmaceutical Spray Drying Market Snippet by End User
    • 2.1.5. Pharmaceutical Spray Drying Market Snippet by Country
    • 2.1.6. Pharmaceutical Spray Drying Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Spray Drying Key Market Trends

  • 3.1. Pharmaceutical Spray Drying Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Spray Drying Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Spray Drying Market Opportunities
  • 3.4. Pharmaceutical Spray Drying Market Future Trends

4. Pharmaceutical Spray Drying Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Spray Drying Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Pharmaceutical Spray Drying Market Landscape

  • 6.1. Pharmaceutical Spray Drying Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Spray Drying Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Spray Dryers (equipment)
    • 7.1.3. Accessories/Consumables
    • 7.1.4. Services (contract spray drying/processing)

8. Pharmaceutical Spray Drying Market - By Drying Configuration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drying Configuration, 2024 & 2032 (%)
    • 8.1.2. Co-current
    • 8.1.3. Counter-current
    • 8.1.4. Mixed-flow

9. Pharmaceutical Spray Drying Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. APIs (active pharmaceutical ingredients)
    • 9.1.3. Excipients
    • 9.1.4. Finished Dosage Forms (e.g., inhalation, oral solid dosage)

10. Pharmaceutical Spray Drying Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Drying Configuration, 2024 & 2032 (%)
    • 10.1.2. Pharmaceutical & Biopharmaceutical Companies
    • 10.1.3. Contract Development & Manufacturing Organizations (CDMOs/CMOs)
    • 10.1.4. Research Institutes & Laboratories

11. Pharmaceutical Spray Drying Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Pharmaceutical Spray Drying Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Pharmaceutical Spray Drying Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Pharmaceutical Spray Drying Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Pharmaceutical Spray Drying Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Pharmaceutical Spray Drying Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Drying Configuration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Pharmaceutical Spray Drying Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. BUCHI Labortechnik AG
    • 12.2.2. Catalent, Inc.
    • 12.2.3. Dedert Corporation
    • 12.2.4. European SprayDry Technologies LLP
    • 12.2.5. Fette Compacting GmbH
    • 12.2.6. GEA Group Aktiengesellschaft
    • 12.2.7. Glatt GmbH
    • 12.2.8. GMP Pharmaceuticals, LLC
    • 12.2.9. Hovione, S.A.
    • 12.2.10. Labultima
    • 12.2.11. Lonza Group AG
    • 12.2.12. Merck KGaA
    • 12.2.13. New AVM Systech Pvt. Ltd.
    • 12.2.14. SiccaDania A/S
    • 12.2.15. SPX FLOW, Inc.
    • 12.2.16. SUDMO GmbH
    • 12.2.17. Swenson Technology, Inc.
    • 12.2.18. Tetra Pak International S.A.
    • 12.2.19. Thermo Fisher Scientific Inc.
    • 12.2.20. Yamato Scientific Co., Ltd.
    • 12.2.21. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제